Volume 30, Number 9—September 2024
Research
Mpox Epidemiology and Risk Factors, Nigeria, 2022
Table 4
Variables | No. (%) |
Univariate analysis |
Multivariate analysis |
||||||
---|---|---|---|---|---|---|---|---|---|
Total | Mpox-pos | Mpox-neg | cOR (95% CI) | p value† | aOR (95% CI) | p value† | |||
Sex at birth | |||||||||
F | 30 (41.1) | 9 (34.6) | 21 (44.7) | Referent | Referent | ||||
M |
43 (58.9) |
17 (65.4) |
26 (55.3) |
1.53 (0.57, 4.11) |
0.403 |
1.56 (0.46, 5.27) |
0.477 |
||
Age group | |||||||||
0–9 y | 42 (57.5) | 15 (57.7) | 27 (57.4) | 1.01 (0.38, 2.66) | 0.984 | 2.03 (0.59, 7.05) | 0.264 | ||
10–1 y |
31 (42.5) |
11 (42.3) |
20 (42.6) |
Referent |
Referent |
||||
Close contact confirmed | |||||||||
Yes | 13 (17.8) | 7 (26.9) | 6 (12.8) | 2.52 (0.74, 8.51) | 0.13‡ | 4.76 (1.14, 19.87) | 0.032 | ||
No |
60 (82.2) |
19 (73.1) |
41 (87.2) |
Referent |
Referent |
||||
Animal exposure§ | |||||||||
Yes | 7 (9.6) | 5 (19.2) | 2 (4.3) | 5.36 (0.96, 29.91) | 0.05‡ | 9.97 (1.27, 78.34) | 0.029 | ||
No |
66 (90.4) |
21 (80.8) |
45 (95.7) |
Referent |
Referent |
||||
Place residence | 0.632 | ||||||||
Rural | 12 (16.4) | 5 (19.2) | 7 (14.9) | 1.36 (0.35, 4.81) | |||||
Urban/semi-urban |
61 (83.6) |
21 (80.8) |
40 (85.1) |
Referent |
|||||
VZV status¶ | 0.001 | ||||||||
Positive | 24 (37.5) | 15 (62.5) | 9 (22.5) | 5.74 (1.89, 17.43) | |||||
Negative | 40 (62.5) | 9 (37.5) | 31 (77.5) | Referent |
*Boldface indicates statistical significance. aOR, adjusted odds ratio; cOR, crude odds ratio; VZV, varicella zoster virus. †p values determined by χ2 tests except as indicated. ‡Fisher exact test. §The 5 mpox-pos children with animal exposures did not report associated contact with a human with suspected mpox. ¶Some VZV status data were missing.
1Additional members of the NIDS study group Nigeria who are co-authors and contributed data to this work are listed at the end of this article.
Page created: July 30, 2024
Page updated: August 22, 2024
Page reviewed: August 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.